AstraZeneca

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AstraZeneca and other ETFs, options, and stocks.

About AZN

AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company’s history roots back to the year 1913 when Astra business was formed. 

CEO
Pascal Soriot
CEOPascal Soriot
Employees
94,300
Employees94,300
Headquarters
Cambridge, Cambridgeshire
HeadquartersCambridge, Cambridgeshire
Founded
1913
Founded1913
Employees
94,300
Employees94,300

AZN Key Statistics

Market cap
276.54B
Market cap276.54B
Price-Earnings ratio
29.51
Price-Earnings ratio29.51
Dividend yield
1.71%
Dividend yield1.71%
Average volume
5.17M
Average volume5.17M
High today
$90.07
High today$90.07
Low today
$88.85
Low today$88.85
Open price
$89.56
Open price$89.56
Volume
3.63M
Volume3.63M
52 Week high
$90.27
52 Week high$90.27
52 Week low
$61.24
52 Week low$61.24

Stock Snapshot

AstraZeneca(AZN) stock is priced at $89.02, giving the company a market capitalization of 276.54B. It carries a P/E multiple of 29.51 and pays a dividend yield of 1.7%.

On 2025-11-19, AstraZeneca(AZN) stock traded between a low of $88.85 and a high of $90.07. Shares are currently priced at $89.02, which is +0.2% above the low and -1.2% below the high.

AstraZeneca(AZN) shares are trading with a volume of 3.63M, against a daily average of 5.17M.

During the past year, AstraZeneca(AZN) stock moved between $61.24 at its lowest and $90.27 at its peak.

During the past year, AstraZeneca(AZN) stock moved between $61.24 at its lowest and $90.27 at its peak.

AZN News

TipRanks 2h
AstraZeneca treatment of multiple myeloma granted orphan designation

AstraZeneca (AZN) Pharmaceuticals’ treatment of multiple myeloma was granted FDA orphan designation status, according to a post to the agency’s website. Meet Y...

TipRanks 2h
AstraZeneca approves AstraZeneca’s Koselugo for adults with NF1

The Food and Drug Administration announced the approval of AstraZeneca’s (AZN) Koselugo for adults with neurofibromatosis type 1 who have symptomatic, inoperabl...

TipRanks 2d
Capital Group Increases Stake in AstraZeneca

Meet Your ETF AI Analyst Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions AI Analyst can help you make smarter investment...

Analyst ratings

81%

of 31 ratings
Buy
80.6%
Hold
16.1%
Sell
3.2%

More AZN News

TipRanks 3d
Clever Culture Systems Gains Industry Validation for APAS® Independence

Meet Your ETF AI Analyst Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions AI Analyst can help you make smarter investment...

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.